M. Nikoloff

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial

J. Cuzick, A. Howell, J. Forbes, 2012, British Journal of Cancer.

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

A. Howell, D. Evans, W. Newman, 2010, Breast Cancer Research and Treatment.

The Impact of Pharmacogenomics on Postoperative Nausea and Vomiting: Do CYP2D6 Allele Copy Number and Polymorphisms Affect the Success or Failure of Ondansetron Prophylaxis?

D. Lubarsky, W. Koch, D. Birnbach, 2005, Anesthesiology.

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

E. Ziv, H. Rugo, A. Wu, 2011, Genome Medicine.

UC San Francisco UC San Francisco Previously Published Works Title Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

E. Ziv, H. Rugo, A. Wu, 2011 .